Syngene International Limited — Financials & Forensics
Sector: Healthcare · NSE: SYNGENE · BSE: 539268 · ISIN: INE398R01022
18 Aug 2026
Add SYNGENE to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹2,604 Cr | ₹3,193 Cr | ₹3,489 Cr | ₹3,642 Cr | ₹3,739 Cr |
| EBITDA | ₹796 Cr | ₹934 Cr | ₹1,014 Cr | ₹1,042 Cr | ₹918 Cr |
| EBITDA margin | 30.6% | 29.3% | 29.1% | 28.6% | 24.6% |
| Profit after tax | ₹396 Cr | ₹464 Cr | ₹510 Cr | ₹496 Cr | ₹317 Cr |
Deeper analysis
Recent filings by Syngene International Limited
-
Investor Presentation
29 Jul 2026 · Financial Results
-
Shareholders meeting
29 Jul 2026 · General Update
-
Resignation of Director/KMP/SMP
29 Jul 2026 · Management Change
-
Resignation of Independent Director
29 Jul 2026 · Management Change
-
Press Release
29 Jul 2026 · Financial Results
Never miss a filing again
About Syngene International Limited on Indian Stock Alerts
Indian Stock Alerts tracks Syngene International Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.